English | 繁體

Search in the results

UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Competition Law Systems in the Western Balkans: Comparative Analysis Presentation
会议地点: International Conference "Possibilities and Limits of Competition Law: Global Trends, Regional Perspective", Jean Monnet South and East European Competition Law Center of Excellence & Croatian Association for Competition Law and Policy, Osijek (Croatia), 会议日期: 3-5 October 2024, 报告日期: 2024-10-04
Authors:  Pecotic Kaufman, J.;  Skara, G.;  Svetlicinii, A.
Favorite |  | Submit date：2024/10/07
Editorial foreword Journal article
Svetlicinii, A., Pecotic Kaufman, J.. Editorial foreword[J]. Yearbook of Antitrust and Regulatory Studies, 2023, 16(27), 5-8.
Authors:  Svetlicinii, A.;  Pecotic Kaufman, J.
Favorite |  | Submit date：2023/11/28
Yearbook of Antitrust and Regulatory Studies 2023 vol. 16(27) Journal
创刊日期: 2023, 出版者: Centre for Antitrust and Regulatory Studies, ISSN: 1689-9024
Authors:  Svetlicinii, A.;  Pecotic Kaufman, J.
Favorite |  | Submit date：2023/11/28
Competition law developments in Central and Eastern Europe: An overview of EU and national case law Journal article
Pecotic Kaufman, J., Svetlicinii, A.. Competition law developments in Central and Eastern Europe: An overview of EU and national case law[J]. Concurrences, 2023(112193), 1-12.
Authors:  Pecotic Kaufman, J.;  Svetlicinii, A.
Favorite |  | Submit date：2023/04/27
Judicial review of decisions of national competition authorities: a comparison of Croatia and Bulgaria Presentation
会议地点: Croatian Competition Law and Policy Association, Zagreb (Croatia), 会议日期: 5 May 2022, 报告日期: 2022-05-05
Authors:  Pecotic Kaufman, J.;  Svetlicinii, A.
Favorite |  | Submit date：2022/07/27
ASCOLA South East Europe Chapter webinars series September–December 2020 Journal article
Pecotic Kaufman, J., Svetlicinii, A.. ASCOLA South East Europe Chapter webinars series September–December 2020[J]. Yearbook of Antitrust and Regulatory Studies, 2021, 14(24), 211-214.
Authors:  Pecotic Kaufman, J.;  Svetlicinii, A.
Favorite |  | Submit date：2022/08/16
Identification of Novel Targets for Lung Cancer Therapy Using an Induced Pluripotent Stem Cell Model Journal article
Shukla, V, Rao, M, Zhang, HE, Beers, J, Wangsa, D, Wangsa, D, Buishand, FO, Wang, YH, Yu, ZY, Stevenson, H, Reardon, E, McLoughlin, KC, Kaufman, A, Payabyab, E, Hong, JA, Zhang, M, Davis, SR, Edelman, DC, Chen, G, Miettinen, M, Restifo, N, Ried, T, Meltzer, PS, Schrump, DS. Identification of Novel Targets for Lung Cancer Therapy Using an Induced Pluripotent Stem Cell Model[J]. ANNALS OF THE AMERICAN THORACIC SOCIETY, 2018, 15, S127-S128.
Authors:  Shukla, V;  Rao, M;  Zhang, HE;  Beers, J;  Wangsa, D; et al.
Favorite | TC[WOS]:1   IF:6.8/6.8 | Submit date：2019/01/09
ASXL3 is a novel pluripotency factor in human respiratory epithelial cells and a potential therapeutic target in small cell lung cancer Journal article
Shukla V., Rao M., Zhang H., Beers J., Wangsa D., Wangsa D., Buishand F.O., Wang Y., Yu Z., Stevenson H.S., Reardon E.S., McLoughlin K.C., Kaufman A.S., Payabyab E.C., Hong J.A., Zhang M., Davis S., Edelman D., Chen G., Miettinen M.M., Restifo N.P., Ried T., Meltzer P.A., Schrump D.S.. ASXL3 is a novel pluripotency factor in human respiratory epithelial cells and a potential therapeutic target in small cell lung cancer[J]. Cancer Research, 2017, 77(22), 6267-6281.
Authors:  Shukla V.;  Rao M.;  Zhang H.;  Beers J.;  Wangsa D.; et al.
Favorite | TC[WOS]:23 TC[Scopus]:21 | Submit date：2018/12/21
The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models Journal article
Sredni B., Xu R.-H., Albeck M., Gafter U., Gal R., Shani A., Tichler T., Shapira J., Bruderman I., Catane R., Kaufman B., Whisnant J.K., Mettinger K.L., Kalechman Y.. The protective role of the immunomodulator AS101 against chemotherapy-induced alopecia studies on human and animal models[J]. International Journal of Cancer, 1996, 65(1), 97-103.
Authors:  Sredni B.;  Xu R.-H.;  Albeck M.;  Gafter U.;  Gal R.; et al.
Favorite | TC[WOS]:68 TC[Scopus]:72  IF:5.7/6.0 | Submit date：2018/12/20